Rapid identification of seven bacterial species using microfluidics, time-lapse phase-contrast microscopy, and deep learning

Erik Hallström,Vinodh Kandavalli,Carolina Wählby,Anders Hast
DOI: https://doi.org/10.1101/2024.10.15.618380
2024-10-18
Abstract:For effective treatment of bacterial infections, it is essential to identify the species causing the infection as early as possible. Currently, the main techniques for determining the species require hours of overnight culturing of a bacterial sample and a larger quantity of cells to function effectively. This study uses one-hour phase-contrast time-lapses of bacterial growth collected from a microfluidic chip, also known as a "mother machine". Then, this data is used to train deep artificial neural networks to identify the species. Both video and image classification models of the Vision Transformer (ViT) and Convolutional Neural Network (CNN) families were evaluated in this study. We have previously demonstrated this approach to classify four different species, which is now extended to seven species: , and . The models are then trained and evaluated using subsampled images, simulating using lower-resolution microscopy in a potential clinical setting. The method can be used simultaneously with phenotypic antibiotic susceptibility testing (AST) in the microfluidic chip. The best models attained an average precision of 93.5% and a recall of 94.7% (0.997 AUC) on a trap basis in a separate, unseen experiment with mixed species within 70 minutes. However, in a real-world scenario, one can assume many traps will contain the actual species causing the infection, improving the reliability. The experiments suggest spatiotemporal features can be learned from video data of bacterial cell divisions. Rapidly identifying bacterial species and simultaneously performing drug sensitivity testing in a much shorter time compared to today — reduced from days to hours or minutes — could lead to a paradigm shift in how initial treatments for severe bacterial infections are chosen. These developments could prove vital in combating antibiotic resistance, improving clinical outcomes, and ultimately saving lives.
Bioinformatics
What problem does this paper attempt to address?